Cerebras is considering an IPO price range of $150 to $160 a share and raising the number of shares marketed to 30 million from 28 million, Reuters reported.
Source: US Top News and Analysis
News Aggregation on Steroids
Cerebras is considering an IPO price range of $150 to $160 a share and raising the number of shares marketed to 30 million from 28 million, Reuters reported.
Source: US Top News and Analysis